Difference between PET and SPECT imaging in oncology

nav.hidden, nav ul [x-cloak], nav ul li ul { display: block !important; } This website requires Javascript for some parts to function properly. Your experience may vary.

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential Essential cookies enable basic functions and are necessary for the website to function properly. Marketing Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Log out

Change Cookie Settings

Forgot Password? Click here

Cookie consent is required to register and log in

I am a Healthcare professional outside US

Subscribe me to the regular newsletter

Notice: The content of this website is not intended for U.S. residents.

This website has implemented reCAPTCHA v3 and your use of reCAPTCHA v3 is subject to the Google Privacy Policy and Terms of Use.

Log out

Change Cookie Settings

Forgot Password? Click here

Cookie consent is required to register and log in

I am a Healthcare professional outside US

Subscribe me to the regular newsletter

Notice: The content of this website is not intended for U.S. residents.

This website has implemented reCAPTCHA v3 and your use of reCAPTCHA v3 is subject to the Google Privacy Policy and Terms of Use.

Difference between PET and SPECT imaging in oncology

Current functional imaging techniques in nuclear medicine, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), play an essential role in clinical oncology by aiding early diagnosis, predicting treatment responses, and monitoring the disease. Do you know the key differences between these two techniques?

Back

Related Assets

Slide kits

Feb 2025

SSTR imaging of NETs

The following slide kit outlines the principles and steps for somatostatin receptor-based imaging, specifically in managing neuroendocrine tumors.

SSTR NET PET-CT

Slide kits

Oct 2024

Basics of radiopharmaceuticals

Learn about the concept of theranostics in oncology and how radiopharmaceuticals, diagnostic and therapeutic compounds labeled with radionuclides, play a central role in this approach.

PET-CT RPT Lu-177